GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Conmed Corp (FRA:EC8) » Definitions » Additional Paid-In Capital

Conmed (FRA:EC8) Additional Paid-In Capital : €421 Mil(As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Conmed Additional Paid-In Capital?


Conmed's quarterly additional paid-in capital declined from Sep. 2023 (€412 Mil) to Dec. 2023 (€409 Mil) but then increased from Dec. 2023 (€409 Mil) to Mar. 2024 (€421 Mil).

Conmed's annual additional paid-in capital increased from Dec. 2021 (€351 Mil) to Dec. 2022 (€390 Mil) and increased from Dec. 2022 (€390 Mil) to Dec. 2023 (€409 Mil).

Conmed Additional Paid-In Capital Historical Data

The historical data trend for Conmed's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Conmed Additional Paid-In Capital Chart

Conmed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 341.39 314.52 351.14 390.09 409.47

Conmed Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 391.83 399.46 412.03 409.47 421.38

Conmed Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Conmed Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Conmed's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Conmed (FRA:EC8) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Conmed Corp (FRA:EC8) » Definitions » Additional Paid-In Capital
Comparable Companies
IART RXST NVCR UFPT IRTC QDEL SINT NARI INMD ESTA ABT SYK BSX MDT XTER:SHL EW DXCM SZSE:300760 XAMS:PHIA ZBH
Traded in Other Exchanges
CNMD:USA EC8:Germany
Address
11311 Concept Boulevard, Largo, FL, USA, 33773
Website
https://www.conmed.com
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.

Conmed (FRA:EC8) Headlines

No Headlines